Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database
Author:
Affiliation:
1. Division of Gastroenterology; Department of Medicine; University of California; San Francisco CA USA
2. Division of Transplant Surgery; Department of Surgery; University of California; San Francisco CA USA
Funder
National Institutes of Health
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14549/fullpdf
Reference40 articles.
1. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996
2. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States;Pomfret;Liver Transpl,2010
3. Liver transplantation for hepatocellular carcinoma in the Model for End-stage Liver Disease era;Levi;J Am Coll Surg,2010
4. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report;Clavien;Lancet Oncol,2012
5. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators;Zimmerman;Arch Surg,2008
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Performance of eight predictive models for hepatocellular carcinoma recurrence after liver transplantation: A comparative study;Annals of Hepatology;2024-03
2. Transplant oncology – Current indications and strategies to advance the field;JHEP Reports;2024-02
3. 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations;Journal of Clinical and Experimental Hepatology;2024-01
4. The Role of PIVKA-II as a Predictor of Early Hepatocellular Carcinoma Recurrence-Free Survival after Liver Transplantation in a Low Alpha-Fetoprotein Population;Cancers;2023-12-19
5. Molecular profiling in the management of hepatocellular carcinoma;Current Opinion in Organ Transplantation;2023-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3